Guangdong Zhongsheng Pharmaceutical Co Ltd Net Asset Momentum
Guangdong Zhongsheng Pharmaceutical Co Ltd net asset momentum. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) recorded a net asset momentum of -11.4% as of December 2024, with net assets of CN¥4.01 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 002317 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Net asset momentum of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. This chart tracks Guangdong Zhongsheng Pharmaceutical Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is -11.4%, with net assets of CN¥4.01 Billion CNY as of December 2024. See Guangdong Zhongsheng Pharmaceutical Co L book value and equity for net asset value and shareholders' equity analysis.
Guangdong Zhongsheng Pharmaceutical Co Ltd Net Asset Momentum by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd net asset momentum by year from 2006 to 2024. The table below shows the complete annual net asset history for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Guangdong Zhongsheng Pharmaceutical Co L market cap and net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.01 Billion | CN¥5.55 Billion | CN¥1.54 Billion | ▼ -11.4% |
| 2023 | CN¥4.53 Billion | CN¥6.46 Billion | CN¥1.93 Billion | ▲ +18.6% |
| 2022 | CN¥3.82 Billion | CN¥5.78 Billion | CN¥1.96 Billion | ▲ +7.9% |
| 2021 | CN¥3.54 Billion | CN¥4.90 Billion | CN¥1.36 Billion | ▼ -2.4% |
| 2020 | CN¥3.63 Billion | CN¥4.78 Billion | CN¥1.15 Billion | ▼ -12.3% |
| 2019 | CN¥4.13 Billion | CN¥5.51 Billion | CN¥1.37 Billion | ▲ +4.6% |
| 2018 | CN¥3.95 Billion | CN¥5.24 Billion | CN¥1.29 Billion | ▲ +5.9% |
| 2017 | CN¥3.73 Billion | CN¥4.86 Billion | CN¥1.13 Billion | ▲ +8.9% |
| 2016 | CN¥3.42 Billion | CN¥4.23 Billion | CN¥801.23 Million | ▲ +62.3% |
| 2015 | CN¥2.11 Billion | CN¥3.33 Billion | CN¥1.22 Billion | ▲ +11.1% |
| 2014 | CN¥1.90 Billion | CN¥2.31 Billion | CN¥407.63 Million | ▲ +8.9% |
| 2013 | CN¥1.74 Billion | CN¥1.98 Billion | CN¥238.04 Million | ▲ +9.8% |
| 2012 | CN¥1.59 Billion | CN¥1.74 Billion | CN¥150.41 Million | ▲ +7.4% |
| 2011 | CN¥1.48 Billion | CN¥1.57 Billion | CN¥92.54 Million | ▲ +6.5% |
| 2010 | CN¥1.39 Billion | CN¥1.48 Billion | CN¥95.53 Million | ▲ +7.1% |
| 2009 | CN¥1.30 Billion | CN¥1.40 Billion | CN¥108.46 Million | ▲ +651.3% |
| 2008 | CN¥172.40 Million | CN¥314.92 Million | CN¥142.53 Million | ▲ +32.0% |
| 2007 | CN¥130.56 Million | CN¥297.74 Million | CN¥167.17 Million | ▼ -5.9% |
| 2006 | CN¥138.72 Million | CN¥291.65 Million | CN¥152.93 Million | — |